Navigation Links
Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea
Date:4/10/2008

SOUTH SAN FRANCISCO, Calif., April 10 /PRNewswire/ -- Napo Pharmaceuticals, Inc., (LSE: NAPL and NAPU) is pleased to announce the positive results of a successfully completed Phase 2 trial for CRO-ID (crofelemer for the treatment of acute adult infectious diarrhea) conducted by its partner, Glenmark Pharmaceuticals Limited (BSE: Glenmark). The primary endpoints of the trial were stool weight, duration of diarrhea, stool frequency and stool consistency; additional endpoints followed include degree of patient dehydration and reduction in gastrointestinal index score.

The conclusions from the study were that treatment with crofelemer was well tolerated and resulted in statistically significant improvements in all the primary endpoints and statistically significant reduction in the additional endpoints as well. Overall clinical success was achieved in 79.1% of the evaluable patients receiving crofelemer compared to 28.2% of the evaluable patients receiving placebo.

There were no drug related adverse events associated with crofelemer.

The Phase 2 study was a randomized, parallel group, double-blind, placebo-controlled which enrolled 98 Indian adult male and female patients aged between 18 to 65 years with acute diarrhea defined as the occurrence of three or more unformed stools (soft or watery consistency) within the 24 hour period preceding entry into the study. Patients suffering from acute infectious diarrhea were dosed 250mg of crofelemer, QID (4 times per day) until recovery or for a maximum of three days. Details regarding the stool weight, stool frequency, stool consistency, duration of diarrhea, and other gastrointestinal symptoms were recorded by the investigators at baseline, and days 1, 2 and 3 of treatment. All patients had a scheduled follow-up visit 30 days after the end of the last dose.

In conclusion, adult Indian patients with infectious diarrhea treated with crofelemer showed a faster recovery with the first dose itsel
'/>"/>

SOURCE Napo Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R)
2. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007
3. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
4. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722
5. Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June
6. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
7. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
8. Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
9. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
10. Medarex Announces Ipilimumab Program Continues to Move Forward
11. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Concord Medical Services Holdings Limited ("Concord Medical", or the "Company") ... operator of the largest network of radiotherapy and diagnostic imaging ... will release its financial results for the second quarter of ... Management will hold a conference call to discuss the ... 18, 2015 (8:00 p.m. in Beijing / ...
(Date:8/4/2015)... , Aug. 4, 2015 Organovo Holdings, ... company focused on delivering scientific and medical breakthroughs ... Company has hired Paul Gallant as ... service and product business. Mr. Gallant has more than ... the drug discovery industry, most recently serving as ...
(Date:8/4/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... and commercialization of targeted antiviral therapies, today announced that ... present live at VirtualInvestorConferences.com on August 6, 2015. ... 12:15PM EDT LINK: http://tinyurl.com/aug6-pre-ctrv ... event where investors are invited to ask the ...
Breaking Medicine Technology:Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 3ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3
... ("CTI") (Nasdaq and MTA: CTIC) today announced that it has ... ("OND") in Maryland and presented its arguments supporting the Company,s ... ("NDA") 22-481 support the conclusion that pixantrone is effective for ... our appeal.  While we understand disputes of this type are ...
... (Nasdaq: KNDL ), a leading, global full-service ... $152.1 million for the fourth quarter of 2010 versus ... book-to-bill improved 25 percent sequentially from the third quarter ... book-to-bill for the quarter was 1.3 as contract cancellations ...
Cached Medicine Technology:FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 2FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 3Kendle Announces Fourth Quarter and Full-Year 2010 Results 2Kendle Announces Fourth Quarter and Full-Year 2010 Results 3Kendle Announces Fourth Quarter and Full-Year 2010 Results 4Kendle Announces Fourth Quarter and Full-Year 2010 Results 5Kendle Announces Fourth Quarter and Full-Year 2010 Results 6Kendle Announces Fourth Quarter and Full-Year 2010 Results 7Kendle Announces Fourth Quarter and Full-Year 2010 Results 8
(Date:8/4/2015)... ... August 04, 2015 , ... Montclair State University and ... the first of its kind in New Jersey, which starting this Fall will help ... and Graduate School partnered with Atlantic Health System, one of the largest health care ...
(Date:8/4/2015)... ... August 04, 2015 , ... Sin City Gallery is delighted ... a diverse group of exceptionally talented female artists. The exhibition premieres at ... September 25-27, 2015 in Downtown Las Vegas. Curated by gallery director Dr. Laura ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... brings an automatic end to driving, says the August 2015 Harvard Health Letter. ... okay to drive. It requires an individual assessment of skills," says Lissa Kapust, ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... in which the physician is board-certified is increasingly influential in their choice of ... , The 2015 ASDS Consumer Survey on Cosmetic Dermatologic Procedures reflects overall consumer ...
(Date:8/4/2015)... , ... August 04, 2015 , ... Rock Your Hair, ... & Rock Beauty Bash Tour. In addition, they have signed Lexi Noel, dubbed the ... appear in forthcoming print and overall branding opportunities for the company. , The ...
Breaking Medicine News(10 mins):Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4Health News:Assessment Can Help Older Drivers Keep Driving Safely, from the August 2015 Harvard Health Letter 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 4Health News:Rock Your Hair Signs On As Title Sponsor For The HYPE! Projects Pop & Rock Beauty Bash Tour 2
... - Counselors from TAPS also provided at event courtesy of ... will,spread holiday cheer to children and spouses of fallen Service ... Dan Band concert at this,year,s Snowball Express gala. TriWest will ... at the event., "We want to show our eternal ...
... needed among minority, underserved women, study finds , ... and background shape women,s attitudes toward mammography, say ... women who underwent screening mammography at the center. ... understanding of mammography and their preferences regarding call-back ...
... CHICAGO, Nov. 26 Women who live in urban ... breast cancer, according,to a study presented today at the ... "Women living in cities need to pay more ... M.B.B.S., F.R.C.S., F.R.C.R.,director of The London Breast Institute at ...
... For the first time, researchers have,identified structural ... The results of the study, conducted by ... in Charlottesville and The Children,s Hospital,of Philadelphia in ... the Radiological Society of North America (RSNA)., ...
... YORK, Nov. 26 People in Medicare ... and could end up paying even more ... to this report from AARP at:, http://media.medialink.com/WebNR.aspx?story=34163 ... audio, text, graphics and,photos for free and ...
... differently to facial expressions than children without psychiatric disorders, ... Hospital researcher. , These findings provide additional insight into ... published in the November issue of the journal Bipolar ... clinically about bipolar disorder in kids, our understanding of ...
Cached Medicine News:Health News:TriWest Sponsors Lt. Dan Band Performance for Families of Fallen Service Members at Snowball Express Gala 2Health News:Understanding of Mammography Differs Among Races 2Health News:City-Dwelling Women at Greater Risk for Breast Cancer 2Health News:Novel MRI Technique Shows Secondhand Smoke Damages Lungs 2Health News:Novel MRI Technique Shows Secondhand Smoke Damages Lungs 3Health News:Facial expressions have greater impact on kids with bipolar disorder 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: